HealthKick Podcast: Dr Chris Behrenbruch on taking Telix Pharma to $1bn and the future of nuclear medicine

Stockhead’s resident health and biotech expert Tim Boreham is putting down the microscope and picking up the microphone for another instalment … Read More

The post HealthKick Podcast: Dr Chris Behrenbruch on taking Telix Pharma to $1bn and the future of nuclear medicine appeared first on Stockhead.

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *